Clinical and Laboratory Profile of Rheumatoid Arthritis Patients at a Highlights from a Study at a Centre in Delhi
,
Abstract
Background: Rheumatoid arthritis is an autoimmune disorder that impacts a significant portion of the population. It results in joint damage, pain, and functional impairment, alongside chronic synovitis. This study aimed to elucidate the Clinical and Laboratory Profile of Rheumatoid Arthritis Patients at a Tertiary Care Institute in Delhi.
Methods: This study involved a retrospective analysis of rheumatoid factor measurements performed on 17,130 serum samples at the Serology and Immunology laboratory from June 2021 to July 2024. The SPECTRUM RF Test Kit (Spectrum Medical Industries, Delhi, India) and the SPECTRUM Automatic Analyzer were employed.
Results: Immunoturbidimetry is an uncomplicated and highly sensitive method for the determination of rheumatoid factor. The quantification of rheumatoid factor via immunoturbidimetry is evidently appropriate for routine diagnostic laboratories. Of 17,130 samples, 1,727 tested positive for rheumatoid factor, exhibiting a slight female predominance. A statistically significant relationship (P value < 0.05) with rheumatoid arthritis was identified in all age groups except for 0-10 years. The highest number of positive cases in our study originated from the Department of Orthopedics, followed by Medicine, Pediatrics, Obstetrics and Gynecology, and Surgery.
Conclusion: Rheumatoid arthritis (RA) is a major burden in North India, particularly in Delhi, with gaps in understanding genetic-environmental interactions (e.g., pollution, diet) and the role of rheumatoid factor in asymptomatic/elderly people. Multidisciplinary research is required to create precise diagnostics, risk models, and targeted therapies for this unique situation. Longitudinal studies and region-specific guidelines are critical for improving outcomes and mitigating RA's socioeconomic impact in this population.
2. Who is a Rheumatologist? https://www.hss.edu/rheumatology-rheumatologist.asp [Accessed 17.09.2024].
3. What is Rheumatology? https://arapc.com/what-is-rheumatology/ [Accessed 17.09.2024].
4. Franceschi C, Garagnani P, Parini P, et al. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 2018; 14:576-90.
5. Kumar V, Chatterjee P, Kumar DA, et al. Epidemiology of geriatric syndromes among older people residing in six old-age homes of Delhi-NCR. WHO South East Asia J Public Health 2021; 10:77-83.
6. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010; 376(9746):1094e1108.
7. Carmona L, Cross M, Williams B, et al. Rheumatoid arthritis. Best Pract Res Clin Rheumatol 2010; 24:733e745.
8. Handa R, Rao URK, Lewis JFM, et al. Literature review of rheumatoid arthritis in India. Int J Rheum Dis 2016; 19:440e451.
9. 2010 ACR/EULAR classification criteria for rheumatoid arthritis. http://www.rheumatology.org/practice/clinical/ classification/ra/ra_2010.asp.
10. Landewe´ RB. The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing. Arthritis Rheum 2003; 48:1-5.
11. Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001; 111:446-51.
12. Bukhari MA, Wiles NJ, Lunt M, et al. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum 2003; 48:46-53.
13. Do¨rner T, Egerer K, Feist E, et al. Rheumatoid factor revisited. Curr Opin Rheumatol 2004; 16:246-53.
14. Feigenbaum SL, Masi AT, Kaplan SB. Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients. Am J Med 1979; 66:377-84.
15. Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis. A systemic analysis of 127 cases. Am J Med 1973; 54:44-52.
16. Virella G, Waller M, Fudenberg HH. Nephelometric method for determination of rheumatoid factor. J Immunol Methods 1978; 22:247-251.
17. Scott DL, Smith C, Kingsley G. Joint damage and disability in rheumatoid arthritis: an updated systematic review. Clin Exp Rheumatol 2003; 21(5 Suppl 31):S20-7.
18. Nielsen SF, Bojesen SE, Schnohr P, et al. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ 2012; 345:e5244.
19. Swedler W, Wallman J, Froelich CJ, et al. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis. J Rheumatol 1997; 24:1037e1044.
20. Hoffman M, Lundberg K, Steiner G. Autoantibodies in rheumatoid arthritis. In: Hochberg MC, Alan JS, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. Philadelphia: Elsevier Ltd; 2015:750e757
21. Sun P, Wang W, Chen L, et al. Diagnostic value of autoantibodies combined detection for rheumatoid arthritis. J Clin Lab Anal 2017; 31:e22086.
22. Wallenius M, Skomsvoll JF, Koldingsnes W, et al. Comparison of work disability and health-related quality of life between males and females with rheumatoid arthritis below the age of 45 years. Scan J Rheumatol 2009; 38(3):178-183.
23. Sokka T, Toloza S, Cutolo M, et al. Women, men, and rheumatoid arthritis: analyses of disease activity,disease characteristics, and treatments in the QUEST-RA study. Arthritis Res The 2009; 11(1):p. R6.
24. Hallert E, Thyberg I, Hass U, et al. Comparison between women and men with recent onset rheumatoid arthritis of disease activity and functional ability over two years (the TIRA project). Annal Rheumatic Dis 2003; 62(7):667-670.
25. Forslind K, Hafström I, Ahlmén M, et al. BARFOT Study Group Sex: a major predictor of remission in early rheumatoid arthritis? Annal Rheumatic Dis 2007; 66(1):46-52.
26. Barragan-Martinez C, Amaya-Amaya J, Pineda-Tamayo R, et al. Gender differences in Latin-American patients with rheumatoid arthritis. Gend Med 2012; 9(6):490-510.
27. Ouali S, Zemri K, Sellam F, et al. Is there an association between anti-citrullinated peptide antibodies and the severity of rheumatoid arthritis parameters in algerian patients? J Drug Deliv Ther 2020; 10(4):17-24.
28. Cutolo M, Sulli A, Capellino S, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004; 13(9):635–8.
29. Al-Mayouf SM, Al Mutairi M, Bouayed K, et al. Epidemiology and demographics of juvenile idiopathic arthritis in Africa and Middle East. Pediatr Rheumatol 2021; 19:166.
30. Young KA, Parrish LA, Zerbe GO, et al. Perinatal and early childhood risk factors associated with rheumatoid factor positivity in a healthy paediatric population. Ann Rheum Dis 2007; 66(2):179-183.
| Issue | Vol 13 No 4 (2025) | |
| Section | Original Articles | |
| Keywords | ||
| Autoimmune disease RA factor Rheumatoid arthritis. | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
